Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Experimental Therapeutics & Oncology|July 17, 2004
Conditionally replicating adenoviruses as anticancer agents and ways to improve their efficacyDinja Oosterhoff, Victor W van Beusechem
Vaccines|July 27, 2026
A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Outer Membrane Vesicle (OMV) Platform-Based Vaccine Administered Intranasally to Healthy AdultsHeleen Kraan, Anne van der Geest, Dinja Oosterhoff, et al.
Frontiers in Immunology|December 11, 2013
Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14(+) Cells at the Cross-Roads of Immune Activation and SuppressionRieneke van de Ven, Jelle J Lindenberg, Dinja Oosterhoff, et al.
Immunotherapy|December 23, 2010
Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunityJelle J Lindenberg, Cynthia M Fehres, Hester van Cruijsen, et al.
The Journal of Investigative Dermatology|November 12, 2010
Irritant-induced migration of Langerhans cells coincides with an IL-10-dependent switch to a macrophage-like phenotypeKrista Ouwehand, Dinja Oosterhoff, Melanie Breetveld, et al.
Frontiers in Immunology|January 6, 2022
An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 InfectionPeter A van der Ley, Afshin Zariri, Elly van Riet, et al.
The Journal of Gene Medicine|January 10, 2012
CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinicBasav N Hangalapura, Laura Timares, Dinja Oosterhoff, et al.
Viruses|October 27, 2022
Construction of a Vero Cell Line Expressing Human ICAM1 for the Development of Rhinovirus VaccinesWouter Johannes Petrus van den Braak, Bella Monica, Diana Limpens, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 18, 2015
Animal models for cutaneous vaccine deliveryHoang J H B Hirschberg, Elly van Riet, Dinja Oosterhoff, et al.
Human Gene Therapy|March 17, 2004
Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion proteinMichelle de Graaf, Herbert M Pinedo, Dinja Oosterhoff, et al.
Pageof 3